about
Drug Development in Alzheimer's Disease: The Contribution of PET and SPECTEarly failure of the default-mode network and the pathogenesis of Alzheimer's diseaseDifferential levels of p75NTR ectodomain in CSF and blood in patients with Alzheimer's disease: a novel diagnostic markerUpdate on the core and developing cerebrospinal fluid biomarkers for Alzheimer disease.Magnetic resonance imaging and positron emission tomography in the diagnosis of neurodegenerative dementias.A platelet protein biochip rapidly detects an Alzheimer's disease-specific phenotypeThe overlap between vascular disease and Alzheimer's disease--lessons from pathology.BACE1 activity impairs neuronal glucose oxidation: rescue by beta-hydroxybutyrate and lipoic acid.Expression of Tau protein in rats with cognitive dysfunction induced by cerebral hypoperfusionMRI visual rating scales in the diagnosis of dementia: evaluation in 184 post-mortem confirmed cases.Presynaptic dystrophic neurites surrounding amyloid plaques are sites of microtubule disruption, BACE1 elevation, and increased Aβ generation in Alzheimer's disease.Alzheimer's disease biomarkers: walk with deliberate haste, don't run blithely on?Alzheimer's Toxic Amyloid Beta Oligomers: Unwelcome Visitors to the Na/K ATPase alpha3 Docking Station.Invited review: Drug development for tauopathies.Neuroimaging and its Relevance to Understanding Pathways Linking Diabetes and Cognitive Dysfunction.Propagation of Aß pathology: hypotheses, discoveries, and yet unresolved questions from experimental and human brain studies.Multimodal PET Imaging of Amyloid and Tau Pathology in Alzheimer Disease and Non-Alzheimer Disease Dementias.Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume.Entorhinal Cortex: Antemortem Cortical Thickness and Postmortem Neurofibrillary Tangles and Amyloid Pathology.18F-FPYBF-2, a new F-18-labelled amyloid imaging PET tracer: first experience in 61 volunteers and 55 patients with dementia.Depressive and anxiety symptoms and cortical amyloid deposition among cognitively normal elderly persons: the Mayo Clinic Study of Aging.Alzheimer's Disease, Oligomers, and Inflammation.Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imagingDetection of Alzheimer's DiseaseEstimation of amyloid distribution by [F]flutemetamol PET predicts the neuropathological phase of amyloid β-protein deposition
P2860
Q26749755-2C5B633D-F359-432F-8382-9410D5F33224Q26862463-156EBFD9-6A95-463B-B0A8-CF4257E75D0BQ27339637-64AE0113-466E-4654-A38F-7277DAC3C6C2Q30845482-DCF82812-B36E-463F-A874-5853A01CBADDQ31153910-65437203-B3F4-4C8A-BC85-5EAEAAE225E6Q34363475-585822D4-0CAD-422D-9E54-FEAE11F5815BQ34484708-63E0EE33-AABA-460A-AE80-73D88EF663ABQ36109558-DD1501D3-CDF6-4DEC-9D1A-18C5343BE300Q36412428-23B3BECB-DC5C-4BD8-93DD-E40CCA392AABQ36724441-82DE1277-CC3A-44DF-993C-E645277B217EQ37099368-FF54A998-D22C-41DC-B611-696B579F513CQ37414970-91018399-EF1F-4818-BC94-70E9D94F899DQ37724402-DBF45F7B-3DAD-461B-84DE-567802DF3CFDQ38263698-326B7034-ECD3-4EBA-9EA6-6264D888F5EBQ38681542-BEF5BE4E-ABEC-492B-BBBC-2F5D69DE10E1Q38682621-D52632A2-B622-4828-8757-B4E39E057B86Q39346750-94B1AA61-4112-41D9-8991-49700A2D7D41Q41151211-D9772CE6-DAAA-441D-BB3B-152C056D8D36Q42619991-14163C9E-7710-463C-8554-EC1C8C74BEAAQ47547512-755DB067-78EA-495A-AF09-7B0520238DCDQ47689619-6D3ACC0C-FA7A-43CD-A5D8-598546125249Q52644596-921FD112-3D0A-4B7D-BEC5-58E056AB5FBBQ58560845-C2F80FF1-B56B-485B-87B3-67C5455F384DQ58706105-0FC464A9-8A43-4641-A4B4-441176D578B0Q58765948-3DD6EC49-F9B1-4252-9895-984B93992FC4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 October 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cerebral amyloid PET imaging in Alzheimer's disease.
@en
Cerebral amyloid PET imaging in Alzheimer's disease.
@nl
type
label
Cerebral amyloid PET imaging in Alzheimer's disease.
@en
Cerebral amyloid PET imaging in Alzheimer's disease.
@nl
prefLabel
Cerebral amyloid PET imaging in Alzheimer's disease.
@en
Cerebral amyloid PET imaging in Alzheimer's disease.
@nl
P2860
P1476
Cerebral amyloid PET imaging in Alzheimer's disease.
@en
P2093
Jorge R Barrio
Vladimir Kepe
P2860
P2888
P304
P356
10.1007/S00401-013-1185-7
P577
2013-10-08T00:00:00Z